Medstar is a supplier of specialist radiotherapy equipment to medical centres in hospitals in China. The Group generates revenues from operating leases through profit sharing agreements with hospitals and/or the sale of medical equipment to such hospitals. Medstar currently operates thirteen centres in nine Chinese cities, Beijing, Shanghai, Guangzhou, Shenyang, Zhengzhou, Jin Zhou, Fuzhou, Nanjing and Dongguan. The Group targets first tier hospitals which are typically located in larger cities, as well as the leading second tier hospitals in the provinces. Chinese expenditure on healthcare has increased from 3.2% of GDP in 1957 to 5.7% in 2003.

THESE SHARES HAVE HAD A BAD START!

You are of course correct and that is obvious - why is the question. Company seems solid and with great potential in a market too big to imagine.

Thanks Oakapples142, needed someone to settle my nerves!!

Good luck Tonker - I have so much tied up in "Medical matters" that its becoming bad fo my health. However, never say never.

t/o of just 4.3 million? ...... that is truly pathetic ...... wonder who did the audit too, as having seen figures from part gov-owned chinese companies, can tell you they often leave much to be desired ...... why on earth buy?

ALWAYS LOOKING FOR A GOOD PROFIT, good to hear from you cynic, glad to hear you still live up to your name... I have done a lot of research on these shares and from what i can see they check out..... providing there is not some big conspiracy, I should do ok? 4.3 million is small, but easy to improve on, what evidence do you have that part gov-owned Chinese companies cook the books ? I do not think China Medstar is gov owned anyway? or are you simply playing up to your name Cynic???!!

first hand since you ask! ..... politest thing to say would be the accounts were not as transparent as demanded by UK laws, or even perhaps as presented by Mr Maxwell and others

Are there any specific examples you can share with me?

no ..... none of your biz just as it's none of mine if you want to put your money in this stock

Kong Yap, Chief Financial Officer of China Medstar, commented: "We are delighted
to be joining the Aim market. Our new shareholders have recognised the Group's
success to date gained through its unique business proposition that our
radiotherapy centres offer Chinese hospitals. We look forward to using the
funds to realise an exciting growth strategy that will further consolidate our
market leading position."